Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 5/20 | 0.76 |
| ▸ | MAPT | P10636 | 5/20 | 0.76 |
| ▸ | KMT2A | Q03164 | 5/20 | 0.76 |
| ▸ | TDP1 | Q9NUW8 | 4/20 | 0.76 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.76 |
| ▸ | MEN1 | O00255 | 4/20 | 0.76 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.76 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.76 |
| ▸ | L3MBTL1 | Q9Y468 | 3/20 | 0.76 |
| ▸ | RAB9A | P51151 | 3/20 | 0.76 |
| ▸ | MITF | O75030 | 2/20 | 0.76 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.76 |
| ▸ | NPC1 | O15118 | 1/20 | 0.76 |
| ▸ | XBP1 | P17861 | 1/20 | 0.76 |
| ▸ | CYP1A2 | P05177 | 4/20 | 0.62 |
| ▸ | CYP3A4 | P08684 | 3/20 | 0.62 |
| ▸ | HTT | P42858 | 2/20 | 0.62 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.62 |
| ▸ | HIF1A | Q16665 | 2/20 | 0.62 |
| ▸ | TP53 | P04637 | 1/20 | 0.62 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Nifuroxime SCHEMBL5025023 | 1.00 | LMNA (0.76) | LMNAMAPTKMT2ATDP1ALDH1A1 | |
| Nifuroxime SCHEMBL465512 | 1.00 | LMNA (0.76) | LMNAMAPTKMT2ATDP1ALDH1A1 | |
| SCHEMBL13461151 | 0.83 | LMNA (0.73) | LMNAMAPTKMT2ATDP1ALDH1A1 | |
| SCHEMBL10680727 | 0.83 | LMNA (0.73) | LMNAMAPTKMT2ATDP1ALDH1A1 | |
| SCHEMBL11779135 | 0.83 | LMNA (0.73) | LMNAMAPTKMT2ATDP1ALDH1A1 | |
| Furaguanidine SCHEMBL30455389 | 0.80 | ALDH1A1 (0.73) | LMNAMAPTKMT2ATDP1ALDH1A1 | |
| SCHEMBL13433883 | 0.79 | LMNA (0.67) | LMNAMAPTKMT2ATDP1ALDH1A1 | |
| SCHEMBL16232908 | 0.79 | LMNA (0.67) | LMNAMAPTKMT2ATDP1ALDH1A1 | |
| SCHEMBL183545 | 0.78 | KMT2A (0.66) | LMNAMAPTKMT2ATDP1ALDH1A1 | |
| Nitrofurazone SCHEMBL25416 | 0.77 | LMNA (1.00) | LMNAMAPTKMT2ATDP1ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 841 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250268998-A1 | METHODS OF TREATMENT FOR CANDIDA AURIS INFECTIONS | LUNDQUIST INSTITUTE FOR BIOMEDICAL INNOVATION AT HARBOR-UCLA MEDICAL CENTER | 2025-08-28 | — | — | US | claimed |
| EP-4101437-B1 | BACTERIOSTATIC COMPOSITION, PREPARATION METHOD THEREFOR AND USE THEREOF | SHENZHEN EULIKAN BIOTECHNOLOGY CO LTD (CN) | 2025-06-11 | — | — | EP | claimed |
| US-12324830-B2 | Methods of treatment for Candida auris infections | LUNDQUIST INSTITUTE FOR BIOMEDICAL INNOVATION AT HARBOR-UCLA MEDICAL CENTER | 2025-06-10 | — | — | US | claimed |
| WO-2025076059-A1 | ROCAGLATE DERIVATIVES AND USES THEREOF | TRUSTEES OF BOSTON UNIVERSITY (US) | 2025-04-10 | — | — | WO | claimed |
| US-20220395481-A1 | BACTERIOSTATIC COMPOSITION, PREPARATION METHOD THEREFOR, AND USE THEREOF | SHENZHEN EULIKAN BIOTECHNOLOGY CO., LTD (CN) | 2022-12-15 | — | — | US | claimed |
| EP-4101437-A1 | BACTERIOSTATIC COMPOSITION, PREPARATION METHOD THEREFOR AND USE THEREOF | Shenzhen Eulikan Biotechnology Co., Ltd. (CN) | 2022-12-14 | — | — | EP | claimed |
| CN-113559264-A | Methods of treating microbial infections including mastitis | 罗达制药公司 | 2021-10-29 | — | — | CN | claimed |
| WO-2021160049-A1 | BACTERIOSTATIC COMPOSITION, PREPARATION METHOD THEREFOR AND USE THEREOF | 深圳优丽康生物技术有限公司 | 2021-08-19 | — | — | WO | claimed |
| CN-113144197-A | Method of treating topical microbial infections | 罗达制药公司 | 2021-07-23 | — | — | CN | claimed |
| CN-111285786-B | Nifuroxazone hapten and artificial antigen as well as preparation method and application thereof | 中国农业大学 | 2021-04-06 | — | — | CN | claimed |
| EP-0743573-A2 | Method for obtaining image contrast migration imaging members | XEROX CORPORATION (US) | 1996-11-20 | — | — | EP | claimed |
| US-5563014-A | SOFTENABLE LAYER CONTAINIG PHOTOSENSITIVE MARKING MATERIAL; TRANSPARENTIZING AGENT | XEROX CORPORATION (US) | 1996-10-08 | — | — | US | claimed |
| US-5514505-A | SELECTIVE TRANSPARENTIZATION OF PHOTOSENSITIVE MIGRATION MARKING PARTICLES EMBEDDED NEAR THE SURFACE OF A SOFTENABLE LAYER SUPPORTED BY AN ELECTROCONDUCTIVE SUBSTRATE | XEROX CORPORATION (US) | 1996-05-07 | — | — | US | claimed |
| US-5482740-A | Sustained release bactericidal cannula | ROCHESTER MEDICAL CORPORATION (US) | 1996-01-09 | — | — | US | claimed |
| EP-0617631-A4 | SUSTAINED-RELEASE BACTERICIDAL CANNULA. | ROCHESTER MEDICAL CORP (US) | 1995-02-22 | — | — | EP | claimed |
| US-5357636-A | Flexible protective medical gloves and methods for their use | DRESDNER JR KARL P (US) | 1994-10-25 | — | — | US | claimed |
| EP-0617631-A1 | SUSTAINED-RELEASE BACTERICIDAL CANNULA | ROCHESTER MEDICAL CORPORATION (US) | 1994-10-05 | — | — | EP | claimed |
| US-5261896-A | Sustained release bactericidal cannula | ROCHESTER MEDICAL CORPORATION (US) | 1993-11-16 | — | — | US | claimed |
| WO-1993011821-A1 | SUSTAINED-RELEASE BACTERICIDAL CANNULA | ROCHESTER MEDICAL CORPORATION (US) | 1993-06-24 | — | — | WO | claimed |
| US-4102998-A | INTRAUTERINE DEVICE WHICH RELEASES MEDICATION | GUTNICK MORTON | 1978-07-25 | — | — | US | claimed |